Jean Alie

Title: Innovations of Jean Alie in Cardiac Treatment

Introduction

Jean Alie is an accomplished inventor based in Montpellier, France. He has made significant contributions to the field of cardiac treatment through his innovative research and development. His work focuses on novel polymorphic forms of a specific compound that has potential therapeutic applications.

Latest Patents

Jean Alie holds a patent for the polymorphic forms of (R)-4-(1-((3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl)sulfonyl)-1-fluoroethyl)-N-(isoxazol-3-yl)piperidine-1-carboxamide. This invention provides novel polymorphs that are useful for treating various cardiac disorders, including systolic dysfunction, dilated cardiomyopathy (DCM), and heart failure with preserved ejection fraction (HFrEF). The patent details the synthesis and characterization of these polymorphs, as well as methods for treating heart disease.

Career Highlights

Jean Alie is currently associated with Myokardia, Inc., where he continues to advance his research in cardiac therapies. His work has been instrumental in developing new treatment options for patients suffering from heart-related conditions. With a focus on innovative solutions, he has established himself as a key figure in the field.

Collaborations

Some of his notable coworkers include Min Zhong and Olivier Monnier. Their collaborative efforts have contributed to the success of the projects they have undertaken together.

Conclusion

Jean Alie's contributions to cardiac treatment through his innovative patents and collaborations highlight his importance in the field of medical research. His work continues to pave the way for advancements in therapies for heart diseases.